HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 206 filers reported holding HERBALIFE LTD in Q3 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $738,308 | +13.0% | 52,774 | +20.2% | 0.09% | -12.3% |
| Q4 2022 | $653,292 | -42.2% | 43,904 | -22.7% | 0.11% | -38.0% |
| Q3 2022 | $1,130,000 | +27.7% | 56,800 | +31.2% | 0.17% | +119.2% |
| Q2 2022 | $885,000 | -70.1% | 43,298 | -55.5% | 0.08% | -69.4% |
| Q1 2022 | $2,957,000 | -32.4% | 97,392 | -8.9% | 0.26% | -23.4% |
| Q4 2021 | $4,377,000 | -4.4% | 106,927 | -1.0% | 0.33% | +1.2% |
| Q3 2021 | $4,577,000 | -1.9% | 108,000 | +22.0% | 0.33% | +6.8% |
| Q2 2021 | $4,667,000 | +6.7% | 88,500 | -10.2% | 0.31% | -1.9% |
| Q1 2021 | $4,374,000 | -3.4% | 98,600 | +4.6% | 0.31% | +2.6% |
| Q4 2020 | $4,530,000 | -36.7% | 94,284 | -38.6% | 0.31% | -35.3% |
| Q3 2020 | $7,161,000 | -2.3% | 153,500 | -5.8% | 0.47% | -5.2% |
| Q2 2020 | $7,332,000 | +19.4% | 163,000 | -22.6% | 0.50% | +2.7% |
| Q1 2020 | $6,139,000 | -15.9% | 210,523 | +37.5% | 0.49% | +8.0% |
| Q4 2019 | $7,297,000 | -64.9% | 153,079 | -72.1% | 0.45% | -63.5% |
| Q3 2019 | $20,778,000 | -1.4% | 548,800 | +11.4% | 1.23% | -0.9% |
| Q2 2019 | $21,064,000 | +1.1% | 492,621 | +25.3% | 1.24% | +5.7% |
| Q1 2019 | $20,838,000 | -11.7% | 393,240 | -1.8% | 1.18% | -10.7% |
| Q4 2018 | $23,598,000 | -4.4% | 400,300 | -11.5% | 1.32% | +28.8% |
| Q3 2018 | $24,684,000 | -24.1% | 452,510 | -25.2% | 1.02% | -17.0% |
| Q2 2018 | $32,506,000 | +10.2% | 605,100 | +99.9% | 1.23% | +23.9% |
| Q1 2018 | $29,504,000 | +33.9% | 302,698 | -7.0% | 1.00% | +55.9% |
| Q4 2017 | $22,031,000 | +139.3% | 325,331 | +139.7% | 0.64% | +110.2% |
| Q3 2017 | $9,205,000 | -4.9% | 135,700 | 0.0% | 0.30% | -21.9% |
| Q2 2017 | $9,679,000 | +22.5% | 135,700 | -0.2% | 0.39% | -6.0% |
| Q1 2017 | $7,904,000 | +3.7% | 135,951 | -14.1% | 0.41% | -17.0% |
| Q4 2016 | $7,622,000 | -21.9% | 158,335 | +0.5% | 0.50% | -12.6% |
| Q3 2016 | $9,763,000 | +39.8% | 157,500 | +32.0% | 0.57% | +3.3% |
| Q2 2016 | $6,983,000 | +9.2% | 119,300 | +14.8% | 0.55% | +38.2% |
| Q1 2016 | $6,396,000 | +66.3% | 103,900 | +44.9% | 0.40% | -24.1% |
| Q4 2015 | $3,845,000 | – | 71,700 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |